Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 12

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
5
Content available remote

Cytokines regulate plasminogen activation system in astrocytoma cells

63%
We report here that human astrocytoma cell line U373-MG is able to express genes of the following components of plasminogen activation system:PAI-1,PN-1,u-PA and t-PA. Treatment of these cells with IL-1 ß results in accumulation of PAI-1,PN-1 and u-PA mRNAs,whereas t-PA mRNA remains unaffected.IFN preferentially enhances PN-1 and PAI-1,EGF enhances PAI-1,u-PA and t-PA expression.Simultaneous addition of anti-inflammatory cytokines IL-4,IL-13 and IL-10 has little effect on the tested components,except induction of u-PA mRNA wich was further enhanced by IL-4.We have confirmed interesting time-dependent regulation of plasminogen activation system by EGF/IFN .Cells stimulated with EGF/IFN show at first increased proteolytic activity but after 24 h inhibition of proteolysis with PAI-1 would prevail.To understand the co- operative effect of EGF and IFN in PAI-1 induction the kinetics of activation of STAT1 was studied.It was found that although EGF alone does not activate STAT1,the STAT1 binding activity in the cells treated with the mixture of EGF/IFN was considerably prolonged.Our results indicate the importance of inflammatory cytokines and EGF in gene regulation of plasminogen activation system in astrocytoma cells.
The horse leucocyte elastase inhibitor (HLEI), present in neutrophils, monecytes and bone marrow cells, is apparently a cytoplasmic protein which is not released from cells even in response to stimulation with lipopolysaccharide, phorbol ester, tumour necrosis factor alpha, interleukin-1 or elastin degradation products. Although no expression of the inhibitor was detected in neutrophils, both monocytes and bone marrow cells were efficient in its synthesis. Using a new expression vector pREST5d, recombinant inhibitor was produced in a large quantity in a soluble form, with a yield of 88 mg per 10 litres of E. colt culture. A two-step purification procedure, consisting of ion-exchange chromatography and gel filtration, yielded 36 mg of the recombinant inhibitor of a purity higher than 95%, as judged by SDS/PAGE. The recombinant protein had physicochemical and kinetic properties indistinguishable from those of the natural one, including irreversible elastase inhibition with an association rate constant kass > 10 7 M -1 s -1. Both proteins were eliminated from rat circulation at the same ratio, and within the first 20 min 70% of the protein was removed. Such a short half-life in the circulation suggests that local delivery of HLEI directly to lungs in the form of aerosol could be a more efficient therapeutic approach than its intravenous injection.
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.